Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

US Patent 8669072 · Granted Mar 11, 2014

Estimated economic value: $22,672,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Boron-containing rho kinase inhibitors2025
Axle structure with asymmetrically arranged brake cylinders2024
Boron-containing diacylhydrazines2020
Chiral diacylhydrazine ligands for modulating the expression of exogenous genes 2020
Boron-containing diacylhydrazine compounds2020
Crystalline diacylhydrazine and the use thereof2019
Boron-containing diacylhydrazines2019
Boron-containing diacylhydrazine compounds2018
Ketone ligands for modulating the expression of exogenous genes via an ecdysone 2017
Crystalline diacylhydrazine and the use thereof2017
Chiral diacylhydrazine ligands for modulating the expression of exogenous genes 2017
Boron-containing diacylhydrazines2016